---
title: Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects
nct_id: NCT04655300
overall_status: COMPLETED
sponsor: Allergan
study_type: OBSERVATIONAL
primary_condition: Age-related Skin Changes
countries: China
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT04655300.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT04655300"
ct_last_update_post_date: 2022-02-15
last_seen_at: "2026-05-12T06:32:07.213Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Evaluation of Age-related Skin Changes Using Clinical Probe Measurements and Imaging Modalities in Chinese Subjects

**NCT ID:** [NCT04655300](https://clinicaltrials.gov/study/NCT04655300)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 102
- **Lead Sponsor:** Allergan
- **Conditions:** Age-related Skin Changes
- **Start Date:** 2021-01-16
- **Completion Date:** 2021-02-05
- **CT.gov Last Update:** 2022-02-15

## Brief Summary

Evaluation of age-related skin changes using clinical probe measurements and imaging modalities in Chinese subjects.

## Eligibility

- **Minimum age:** 20 Years
- **Maximum age:** 79 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* Chinese subjects
* Subject agreeing to complete all study required procedures.
* Subject having given freely and expressly his/her informed consent.

Exclusion Criteria:

* Pregnant or nursing woman or planning a pregnancy during the study.
* Subject who had been deprived of their freedom by administrative or legal decision or who is under guardianship.
* Subject in a social or sanitary establishment.
* Subject participating to another research on human beings or being in an exclusion period for a previous study.
* Intensive exposure to sunlight or UV-rays within the previous month and foreseen during the study.
* Subject who underwent tissue augmentation with dermal fillers including HA, calcium hydroxylapatite, autologous fat, mesotherapy, or other cosmetic procedures (eg, face-lift, laser, photomodulation, intense pulsed light, radiofrequency, dermabrasion, chemical peel, or other ablative procedures) in the face within 12 months before study entry or was planning to undergo any such treatment during the study.
* Subject who underwent treatment with botulinum toxins in the face or neck within 6 months of study entry or was planning to undergo such treatment during the study.
* Subject who ever received semi-permanent fillers or permanent facial implants (eg, poly-L-lactic acid, polymethylmethacrylate, silicone, expanded polytetrafluoroethylene) anywhere in the face or was planning to be implanted with any of these products at any time during the study.
* Subject with current cutaneous inflammatory or infectious processes (eg, acne, herpes), abscess, an unhealed wound, or a cancerous or precancerous lesion on the face that could interfere with measurements.
* Subject having changed, started or stopped any hormonal treatment or any treatment likely to have an impact on skin condition (over-the-counter or prescription, oral or topical, anti-wrinkle products on the face), within 30 days prior to enrollment or is planning to begin using such products during the study.
```

## Arms

- **Group 1**
- **Group 2**
- **Group 3**
- **Group 4**
- **Group 5**
- **Group 6**

## Primary Outcomes

- **Age-related changes in skin hydration on the cheeks, forehead, neck and around the mouth** _(time frame: 2 Months)_ — Skin hydration will be measured using tissue dielectric constant measurement. Tissue dielectric constant is expressed as a unitless value that is directly proportional to the amount of water in the tissue.
- **Age-related changes in skin elasticity on the cheeks, forehead and neck** _(time frame: 2 Months)_ — Skin elasticity measurement using suction based device
- **Age-related changes in skin color on the cheeks and forehead** _(time frame: 2 Months)_ — Skin colorimetric measurement will be done with a Spectrophotometer
- **Age-related changes in skin thickness on the cheek** _(time frame: 2 Months)_ — Epidermal thickness will be measured with an optical coherence tomography instrument
- **Age-related changes in skin blood flow on the cheek** _(time frame: 2 Months)_ — Blood Flow (redness) will be measured with an optical coherence tomography instrument
- **Age-related changes in skin roughness on the cheek** _(time frame: 2 Months)_ — Skin surface roughness will be measured with an optical coherence tomography instrument
- **Age-related changes in skin OAC on the cheek** _(time frame: 2 Months)_ — Optical Attenuation Coefficient (OAC) will be measured with an optical coherence tomography instrument
- **Age-related changes in skin topography on the cheeks, forehead and around the mouth** _(time frame: 2 Months)_ — Skin topography imaged using a using a fringe projection imaging system. Output measurements from the images will include Ra (average roughness), Rq (Root Mean Square of the profile heights), RMax (Maximum Roughness Depth), Rv (Depth of the Largest Profile Valley), Rvm (Average depth of the Profile Valleys), Rz (average height of roughness) and Rt (maximum height of the roughness profile)
- **Age-related changes in gloss/shine, pores, skin color and texture on the cheek, forehead and around the mouth** _(time frame: 2 Months)_ — Skin gloss (Shine, pores, skin color and texture ) imaged using a camera-based system which uses various lighting/capture modalities to enhance the visualization of skin features
- **Clinical scoring of age-related changes in fine lines on the cheek** _(time frame: 2 Months)_ — The investigator will assess the participant's appearance of fine lines/wrinkles using a 5-point scale from (0=None to 4=Diffuse)
- **Clinical scoring of age-related changes in skin roughness on the cheek** _(time frame: 2 Months)_ — The investigator will assess the participant's appearance of skin roughness using a 5-point scale from (0=None to 4=Diffuse)

## Secondary Outcomes

- **To correlate the age-related skin hydration measurements on the cheeks, forehead, neck and around the mouth to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin elasticity measurements on the cheeks, forehead and neck to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin color measurements on the cheeks and forehead to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin thickness measurements on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin blood flow measurements on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin roughness measurements on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin OAC measurements on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin topography measurements on the cheeks, forehead and around the mouth to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related gloss/shine, pores, skin color and texture on the cheek, forehead and around the mouth to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related fine lines on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **To correlate the age-related skin roughness on the cheek to clinical scoring of fine lines and skin smoothness.** _(time frame: 2 Months)_
- **Age-related changes and repeatability in the perioral area for hydration and topography.** _(time frame: 2 Months)_
- **Age-related changes and repeatability in the neck for hydration and elasticity.** _(time frame: 2 Months)_
- **Age related changes and repeatability in the forehead for hydration, color, elasticity, topography, skin gloss, color, texture, pores.** _(time frame: 2 Months)_

## Locations (1)

- Eurofins China, Haizhu, Guangzhou, China

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.eurofins china|haizhu|guangzhou|china` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT04655300.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT04655300*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*